Generalizability of PGS313 for breast cancer risk in a Los Angeles biobank.

Saved in:
Bibliographic Details
Title: Generalizability of PGS313 for breast cancer risk in a Los Angeles biobank.
Authors: Shang H; Division of Internal Medicine, Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA; Department of Computer Science and Engineering, University of Texas at Arlington, Arlington, TX, USA. Electronic address: hshang@mednet.ucla.edu., Ding Y; Bioinformatics Interdepartmental Program, University of California, Los Angeles, Los Angeles, CA, USA., Venkateswaran V; Department of Oral Biology, UCLA School of Dentistry, Los Angeles, CA, USA., Boulier K; Division of Cardiology, Department of Medicine, Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA., Kathuria-Prakash N; Division of Hematology-Oncology, Department of Medicine, Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA., Malidarreh PB; Department of Computer Science and Engineering, University of Texas at Arlington, Arlington, TX, USA; Multi-Interprofessional Center for Health Informatics, University of Texas at Arlington, Arlington, TX, USA., Luber JM; Department of Computer Science and Engineering, University of Texas at Arlington, Arlington, TX, USA; Multi-Interprofessional Center for Health Informatics, University of Texas at Arlington, Arlington, TX, USA; Department of Bioengineering, University of Texas at Arlington, Arlington, TX, USA., Pasaniuc B; Bioinformatics Interdepartmental Program, University of California, Los Angeles, Los Angeles, CA, USA; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; Department of Computational Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA; Institute of Precision Health, University of California, Los Angeles, Los Angeles, CA, USA.
Source: HGG advances [HGG Adv] 2024 Jul 18; Vol. 5 (3), pp. 100302. Date of Electronic Publication: 2024 May 03.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101772885 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-2477 (Electronic) Linking ISSN: 26662477 NLM ISO Abbreviation: HGG Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-2477
DOI:10.1016/j.xhgg.2024.100302